-
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Consensus Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 16 Nov 2024 04:01:19 America/New_York
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 16, 2024 Share Link copied to clipboard. Shares of Adverum Biotechnologies, Inc.
Read more...